• Study Resource
  • Explore Categories
    • Arts & Humanities
    • Business
    • Engineering & Technology
    • Foreign Language
    • History
    • Math
    • Science
    • Social Science

    Top subcategories

    • Advanced Math
    • Algebra
    • Basic Math
    • Calculus
    • Geometry
    • Linear Algebra
    • Pre-Algebra
    • Pre-Calculus
    • Statistics And Probability
    • Trigonometry
    • other →

    Top subcategories

    • Astronomy
    • Astrophysics
    • Biology
    • Chemistry
    • Earth Science
    • Environmental Science
    • Health Science
    • Physics
    • other →

    Top subcategories

    • Anthropology
    • Law
    • Political Science
    • Psychology
    • Sociology
    • other →

    Top subcategories

    • Accounting
    • Economics
    • Finance
    • Management
    • other →

    Top subcategories

    • Aerospace Engineering
    • Bioengineering
    • Chemical Engineering
    • Civil Engineering
    • Computer Science
    • Electrical Engineering
    • Industrial Engineering
    • Mechanical Engineering
    • Web Design
    • other →

    Top subcategories

    • Architecture
    • Communications
    • English
    • Gender Studies
    • Music
    • Performing Arts
    • Philosophy
    • Religious Studies
    • Writing
    • other →

    Top subcategories

    • Ancient History
    • European History
    • US History
    • World History
    • other →

    Top subcategories

    • Croatian
    • Czech
    • Finnish
    • Greek
    • Hindi
    • Japanese
    • Korean
    • Persian
    • Swedish
    • Turkish
    • other →
 
Profile Documents Logout
Upload
Drugs: Antagonists, agonists, and reuptake inhibitors Drugs—why
Drugs: Antagonists, agonists, and reuptake inhibitors Drugs—why

... similar ways. Furthermore, both drugs increase the amount of dopamine in the synapse. However, cocaine achieves this action by preventing dopamine reuptake, while amphetamine helps to release more dopamine. So, these drugs with similar effects produce their actions through entirely different process ...
Read More - WuXi NextCODE
Read More - WuXi NextCODE

... Chunshan, manager of the cooperation department of CAS’s Institute of Genetics and Development Biology (IGDB). The CAS, along with the government of Changzhou City, is building the ¥2 billion (US$322 million) Genetic Resources R&D Center (South) in the high-tech zone of the city in Southern China. T ...
Ecstasy and Club Drugs
Ecstasy and Club Drugs

... Ecstasy is an illegal drug (it was declared illegal by the federal government in 1985) 90% of which is manufactured in the Netherlands and Belgium. In its most common form, Ecstasy is a small tablet that is impressed with any one of a number of logos intended to attract young people. It can also be ...
Drug Drug Interactions - American Association of Nurse Anesthetists
Drug Drug Interactions - American Association of Nurse Anesthetists

... 222 South Prospect Avenue Park Ridge, IL 60068-4001 Copyright ©2016 American Association of Nurse Anesthetists All rights reserved. This book is protected by copyright. No part of it may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, ...
A Patient of Poisoning in ICU
A Patient of Poisoning in ICU

... • Could potentially be cleared from the gut • Reduced total dose of the drug • Reduced total toxicity • Ergo, the removal of undissolved drugs should reduce the toxicity of the overdose!! ...
Drugs and driving don`t mix booklet
Drugs and driving don`t mix booklet

... This includes alcohol, prescription and/or illicit drugs. ■ Often illicit drugs contain more than one drug. Drug manufacturers will do this to save money by using different cheaper chemicals, or to achieve a different effect. To avoid unintended polydrug use with medications always follow instructio ...
1-Renal excretion of drugs
1-Renal excretion of drugs

... Two structurally similar drugs having similar ionic charge and employing the same carriermediated process for excretion enter into competition. ...
Drug Deletions - Texas Department of State Health Services
Drug Deletions - Texas Department of State Health Services

... amphetamines. In addition, he had a blood alcohol concentration of 0.102%. His baseline LFTs are unknown. Collateral documents indicate that he is “addicted to Xanax.” On admission (7-3-12), he was started on clonazepam (Klonopin®) 0.5 mg BID, hydroxyzine (Atarax®) 50 mg BID, sertraline (Zoloft®) 50 ...
PowerPoint_Chapter1
PowerPoint_Chapter1

...  Are categorized in various ways, some based on legal divisions and others on mechanism of action  Must be tested before it is marketed  Has three different names during testing process Chemical name of new medical molecule Generic name assigned by government agency Brand name assigned by comp ...
8NMJ
8NMJ

... Blocking Drugs • Nondepolarizing (competitive) ...
Pharmacology MCQs
Pharmacology MCQs

... will be the same for all dosage forms if the same amounts of the drug is used. d. can be determined by estimating the area under the concentration-effect curve. ...
Detection of drug abuse and misuse using biological samples
Detection of drug abuse and misuse using biological samples

... heroin use. Immunoassays currently marketed for detection of opiate abuse use antibodies raised against morphine. This confers a high sensitivity to structurally related opiates and opioids, such as 6-AM, codeine, hydrocodone, and hydromorphone, but provides little cross-reactivity with oxycodone an ...
Drug Inter. - Dr.
Drug Inter. - Dr.

... Are most GJ/Drug Interactions problems factored in during drug testing ? ...
Early treatment of psychosis
Early treatment of psychosis

... Copyright holders of content included in this material should contact open.michigan@umich.edu with any questions, corrections, or clarification regarding the use of content. For more information about how to cite these materials visit http://open.umich.edu/education/about/terms-of-use. Any medical i ...
Amberlite IRP69 -- Technical Data Sheet
Amberlite IRP69 -- Technical Data Sheet

... fine powder. AMBERLITE IRP69 resin is suitable for use in pharmaceutical applications, both as an active ingredient and as a carrier for basic (cationic) drugs. It can be used for sustained release applications with compatible coating technologies. Regulatory Status A Drug Master File for AMBERLITE ...
Permeability Enhancement Techniques for Poorly Permeable Drugs
Permeability Enhancement Techniques for Poorly Permeable Drugs

... drugs. It has been demonstrated that formulations have influence on intestinal permeation of both transcellularly and paracellularly transported drugs. They can, therefore find their use for actives with either low permeability or low solubility or a combination of both problems (BCS class 2, 3 & 4 ...
9Noval Drug Delivery System
9Noval Drug Delivery System

... research compared that for discovery of new molecule,  Minimizing the drug use would significantly reduce the effective cost of drug which would give financial relief to the patients,  Delivery systems increase commercial opportunity by distinguishing a drug from competitive threats posed by “me t ...
Psychedelics 101 student notes psychedelic101lessonStudent
Psychedelics 101 student notes psychedelic101lessonStudent

... the best course of action was for his/her community. These drugs were held in high regard, treated with ...
Review Pharmacodynamic and pharmacokinetic interactions
Review Pharmacodynamic and pharmacokinetic interactions

... Though certain problems may occur when both types of medicines are taken together, they have not been adequately analyzed. It was reported that anticoagulation was enhanced in addition to bleeding when patients took long-term warfarin therapy in combination with Salvia miltiorrhiza (danshen), and la ...
m5zn_a6cb78119c5a815
m5zn_a6cb78119c5a815

... b- fetal risk NOT demonstrated in animal studies but there are no controlled studies in pregnant women or animal reproduction studies have shown an adverse effect that was NOT confirmed in controlled studies in women during trimester c-either animal study have revealed adverse effect on the fetus an ...
Best Practices: Prescription Drugs and Chronic Pain
Best Practices: Prescription Drugs and Chronic Pain

... A Prescription for Mitigating MSA Settlement Costs ...
Systemic Treatment Clinical Trials Request Intake Form
Systemic Treatment Clinical Trials Request Intake Form

... The purpose of this form is to assess whether the cancer drugs used in the clinical trial or subsequent to the clinical trial can be publicly reimbursed, as well as the funding for the drug preparation, administration and delivery, and related clinical care for patients. The request will be reviewed ...
Herbal Remedies: Drug-Herb Interactions
Herbal Remedies: Drug-Herb Interactions

... several chemotherapeutic agents) were developed from plants. So, indeed, herbs can be potent products. Herbs can affect body functions; therefore, when herbs are taken concurrently with drugs, interactions are possible. Botanical medications have increased in popularity. In the United States, botani ...
Illegible Handwriting Illegible Handwriting Illegible Handwriting
Illegible Handwriting Illegible Handwriting Illegible Handwriting

... I got the order from the patient’s “prior medical records.” “Mom (or the patient) said they take it this way.” It was “on a list of medications that the patient gave me.” The Formulary, April 1999 ...
I`ve heard that I should not consume grapefruit products while taking
I`ve heard that I should not consume grapefruit products while taking

... CPS (Compendium of Pharmaceuticals and Specialties with eTherapeutics) ...
< 1 ... 61 62 63 64 65 66 67 68 69 ... 161 >

Orphan drug

An orphan drug is a pharmaceutical agent that has been developed specifically to treat a rare medical condition, the condition itself being referred to as an orphan disease.In the US and EU it is easier to gain marketing approval for an orphan drug, and there may be other financial incentives, such as extended exclusivity periods, all intended to encourage the development of drugs which might otherwise lack a sufficient profit motive. The assignment of orphan status to a disease and to any drugs developed to treat it is a matter of public policy in many countries, and has resulted in medical breakthroughs that may not have otherwise been achieved due to the economics of drug research and development.According to Thomson Reuters in their 2012 publication ""The Economic Power of Orphan Drugs"", there has been increased investing in orphan drug Research and Development partly due to the U. S. Orphan Drug Act (ODA) 1983 and similar Acts in other regions of the world and also driven by ""high-profile philanthropic funding."" The period between 2001 to 2011 was the ""most productive period in the history of orphan drug development, in terms of average annual orphan drug designations and orphan drug approvals."" For the same decade the compound annual growth rate (CAGR) of the orphan drugs was an ""impressive 25.8 percent, compared to only 20.1 percent for a matched control group of non-orphan drugs."" By 2012 the market for orphan drugs was worth USD$637 million compared to the USD$638 million matched control group of non-orphan drugs, Thomson Reuters.By 2012, ""the revenue-generating potential of orphan drugs [was] as great as for non-orphan drugs, even though patient populations for rare diseases are significantly smaller. Moreover, we suggest that orphan drugs have greater profitability when considered in the full context of developmental drivers including government financial incentives, smaller clinical trial sizes, shorter clinical trial times and higher rates of regulatory success.""
  • studyres.com © 2025
  • DMCA
  • Privacy
  • Terms
  • Report